We harness the power of artificial intelligence to transform healthcare outcomes. Our predictive models help physicians identify risks earlier and deliver more personalized care.
Our suite of predictive tools empowers healthcare providers to make data-driven decisions and deliver proactive patient care.
Advanced machine learning models that analyze patient data to predict potential health conditions before symptoms appear.
Continuous AI-powered monitoring systems that track vital signs and alert healthcare providers to anomalies instantly.
AI-driven solutions for safer care and better patient outcomes.
Deep analytics platform that tracks treatment efficacy and helps optimize patient care pathways for better outcomes.
We're on a mission to revolutionize healthcare through the power of artificial intelligence. Entrusted in Pittsburgh's thriving tech and medical ecosystem, we combine world-class AI research with deep clinical expertise.
OpAIx was born from a clear realization: decades of patient care and pain research revealed an urgent need to predict and prevent pain before it fully develops. With a focus on addressing the US opioid crisis, we leverage AI to transform pain prediction and early intervention. Founded in 2025 by physicians and AI researchers from UPMC, our mission is to bridge cutting-edge artificial intelligence with practical, real-world medicine.
Pittsburgh stands at the forefront of innovation. With world-renowned medical and computer science centers and leading academic institutions, the city offers an ideal ecosystem for developing and validating predictive healthcare solutions.
Today, our algorithms help thousands of healthcare providers identify at-risk patients and intervene early, transforming reactive medicine into proactive care. We're proud to be at the forefront of the predictive medicine revolution.
"To empower healthcare providers with AI-driven insights that predict health outcomes, enabling earlier interventions and transforming reactive medicine into proactive care."
Meet the visionaries behind OpAIx — a team of physicians, researchers, and entrepreneurs united by a passion for transforming healthcare.
Focused on building AI tools that make clinicians more effective and elevate the accuracy and speed of patient care. She turns complex data and machine-learning research into solutions clinicians can actually use, improving decision-making, streamlining diagnostics, and enabling better outcomes at scale.
Dr. Chelly has over 30 years of clinical research experience and developed the Department of Anesthesiology and Perioperative Medicine’s Clinical Research Program, which has enrolled thousands of research subjects since July 2002.
AI & ML product leader with two decades of building and scaling data-driven products. Specialized in transforming complex machine-learning research into commercially successful, user-centric solutions. Known for shipping fast, aligning cross-functional teams, and driving measurable business impact across enterprise and consumer platforms.
Join leading healthcare providers who trust OpAIx to improve patient outcomes through intelligent predictive analytics.